Notably, the anti‐inflammatory and antioxidant effects of NAM in NAFLD models are likely related to its activation of SIRT1 by de‐repressing SIRT1 expression and providing its activator, NAD+. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.